Status:
RECRUITING
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Ontario Institute for Cancer Research
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The Marathon of Hope Cancer Centres Network (MOHCCN) is a national network of cancer centres that pursue collaborative cancer research in precision medicine (an emerging approach for disease treatment...
Detailed Description
The purpose of this study is to use evolving technologies such as genomics and artificial intelligence to study cancer so that the right treatment can be given to the right patient, at the right time....
Eligibility Criteria
Inclusion
- Patients with histological and/or cytological confirmation of blood or solid tumor malignancies. For tumour types where pre-surgical biopsy is not routinely performed to confirm a pathologic diagnosis of cancer, patients may consent to this protocol, but eligibility must be confirmed after pathology is finalized demonstrating presence of malignancy
- All patients must be able to satisfy the required minimum data elements for the 15k gold standard cohort through:
- Already existing data that satisfies the minimal requirements of a gold standard case (refer to Table 1)
- Have sufficient biospecimens (tumor and/or blood samples) available for more comprehensive molecular and immunophenotypic characterization
- Patients who do not satisfy the required minimum data elements but would like to participate, maybe requested to donate blood and undergo a fresh biopsy if the archived Formalin-fixed paraffin-embedded (FFPE) samples are not available, or in cases where a fresh tumor biopsy is deemed necessary for molecular profiling.
- Participating patients must agree to share their anonymized clinical and genomic data
Exclusion
- None.
Key Trial Info
Start Date :
June 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05403177
Start Date
June 23 2022
End Date
October 1 2026
Last Update
February 3 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston Health Sciences Centre
Kingston, Ontario, Canada, K7L 2V7
2
Ottawa Health Research Institute
Ottawa, Ontario, Canada, K1Y 4E9
3
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G2M9